drugset
drugset / Trial / NCT07314320

A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men

NCT07314320 ↗

Phase 1 Completed 8 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the relative amounts of radioactivity excreted in urine and feces following a single oral dose of \[14C\]-OPC-167832 in healthy male participants.

Timeline

Start
2023-11-20
Primary completion
2023-12-27
Completion
2023-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Quabodepistat Small molecule — Oral

Indications

No indication recorded.